News

Patent Eligibility Law Reform

by Nafsika Karavida The Likely Reintroduction of the Patent Eligibility Reform Act The Patent Eligibility Reform Act ("PERA")[1] is expected to be reintroduced under the current Trump administration. Many in the patent law and innovation sectors believe that the administration’s pro-business stance, emphasis on intellectual property rights, and a conservative-leaning Supreme...

Read More

Nafsika Karavida Discusses U.S. and EU Approaches to Vaccine Patents and Compulsory Licensing Amid COVID-19

Governments, pharmaceutical companies and medical researchers around the world are racing to produce a vaccine for COVID-19, as well as potential drugs to fight the virus in those who contract it. The numbers show at least 70 reported potential vaccines and 150 other drugs for treatment that are in development...

Read More